SynthesisFrontiers in oncology2024

Efficacy and safety of first-line immune checkpoint inhibitor combination therapies in patients with advanced esophageal squamous cell carcinoma: a network meta-analysis.

Chenglong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.